Medicinova (MNOV) Recent Earnings
Medicinova (MNOV) reported a 1st Quarter March 2022 loss of $0.07 per share on revenue of $0.0 million. The consensus estimate was a loss of $0.09 per share. Revenue fell 100.0% compared to the same quarter a year ago.
MediciNova Inc is a development stage biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.